CJEU C-423/17: Carve-out Limits the Scope of Marketing Authorisation of Generic Medicines journal article Vicky N Kriketou European Pharmaceutical Law Review, Volume 3 (2019), Issue 1, Page 46 - 49
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás